Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Blinding01:11

Blinding

Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Observer agreement for a novel visual rating scale of vermian atrophy in childhood ataxia telangiectasia.

AJNR. American journal of neuroradiology·2026
Same author

The DREAMS START intervention for sleep in dementia: Long-term follow-up of a randomized controlled trial.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

The clinical and cost-effectiveness of improving sleep via carer delivered strategies in people with dementia: the DREAMS START parallel multi-centre RCT.

Health technology assessment (Winchester, England)·2026
Same author

Family interventions in dementia mental health environments (FIND ME): a mixed-methods protocol.

BMJ open·2026
Same author

The Nottingham consensus on dementia risk reduction policy: recommendations from a modified Delphi process.

Nature reviews. Neurology·2026
Same author

Posterior Reversible Encephalopathy Syndrome (PRES) Following Fruquintinib in a Normotensive Patient With Metastatic Colorectal Cancer: A Case Report.

Cureus·2025

Related Experiment Videos

Acceptance checklist for clinical effectiveness pilot trials: a systematic approach.

Georgina Charlesworth1, Karen Burnell, Juanita Hoe

  • 1Research Department of Clinical, Educational and Health Psychology, University College London, 1-19 Torrington Place, London WC1E 7HB, UK. g.charlesworth@ucl.ac.uk

BMC Medical Research Methodology
|June 14, 2013
PubMed
Summary

Pilot trials are crucial for larger studies, especially when data can be pooled. This study introduces a checklist to ensure pilot data integrity for subsequent trials, optimizing research investment.

Related Experiment Videos

Area of Science:

  • Clinical Trials Methodology
  • Health Services Research
  • Gerontology

Background:

  • Pilot trials are essential for planning and justifying larger clinical trials.
  • Pooling data from pilot and main trials offers ethical and financial advantages.
  • Maintaining methodological consistency is vital, particularly for explanatory trials prioritizing internal validity.

Purpose of the Study:

  • To develop a decision-making checklist for assessing the suitability of carrying forward pilot trial data to the main trial dataset.
  • To ensure the integrity of trial data when pooling results from pilot and main studies.
  • To provide guidance for pragmatic trials where real-world variations are incorporated.

Main Methods:

  • Development of a checklist to evaluate the comparability of pilot and main trial data.
  • Illustration of the checklist's application using a case study of a pragmatic trial.
  • Focus on decision-making criteria for data pooling without compromising trial integrity.

Main Results:

  • A structured checklist was developed to aid researchers in determining whether pilot data can be integrated into the main trial dataset.
  • The case study demonstrated the practical utility of the checklist in a real-world pragmatic trial setting.
  • The checklist facilitates informed decisions regarding data pooling, safeguarding the overall trial integrity.

Conclusions:

  • The developed checklist provides a systematic approach to ensure pilot data integrity when pooling with main trial data.
  • Utilizing the checklist enhances the ethical and financial efficiency of multi-phase clinical trials.
  • This tool is particularly valuable for pragmatic trials, balancing internal validity with external generalizability.